摘要
目的观察新型泪道扩张引流管置入治疗鼻泪管阻塞的实用性和有效性.方法对116例（117眼）鼻泪管阻塞患者行新型泪道扩张引流管置入术.根据不同性别、不同病程长短进行分组,比较拔管1个月后不同组间的治愈率,用生存分析绘制拔管远期成功率曲线图.结果不同性别、不同病程长短各组间治愈率差异均无统计学意义.至随访截止时在治愈的95眼中共有23眼复发,随访1年复发率约为7%,2年复发率约为17%,3年复发率约27%,3年后趋于稳定.结论新型泪道扩张引流管置入治疗鼻泪管阻塞近、远期效果良好,治愈率不受性别及病程的影响,是一种有效、安全、微创、简便的治疗方法.
Objective To evaluate the feasibility and efficacy of novel dilation drainage tube implantation for nasolacrimal duct obstruction. Methods One hundred and sixteen cases of nasolacrimal duct obstruction （117 eyes） were enrolled in the study. Novel dilation drainage tube was implanted into the nasolacrimal duct in each eye. Cure rate was compared by χ2 test between different gender groups and different course of disease groups 1 month after tube removal. The probability of recurrence with time was plotted using life tables survival analysis. Results There were no statistically significant differences in the cure rate between different gender groups （P 〉0.05） or different course of disease groups （P 〉0.05）. At the end of follow-up, recurrence was observed in 23 of total 95 eyes. The probability of recurrence rate was 7% at 1 year, 17% at 2 years and 27% at 3 years. Conclusion Implantation of novel dilation drainage tube is an effective, minimally invasive and simple method for nasolacrimal duct obstruction
出处
《浙江医学》
CAS
2012年第21期1747-1750,共4页
Zhejiang Medical Journal
关键词
泪道扩张引流管
鼻泪管阻塞
慢性泪囊炎
Dilation drainge tube Nasotacrimal duct obstruction Chronic dacryocystitis
